SAREPTA THERAPEUTICS INC (SRPT) Stock Analyst Earnings Estimates
NASDAQ:SRPT - Nasdaq - US8036071004 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 701.9M 29.96% | 933M 32.92% | 1.243B 33.26% | 1.894B 52.33% | 3.215B 69.75% | 3.977B 23.70% | 4.47B 12.40% | 4.527B 1.28% | 4.405B -2.69% | 4.491B 1.95% | 4.56B 1.54% | 4.677B 2.57% | |
| EBITDA YoY % growth | -411.7M 23.38% | -494.3M -20.06% | -223.427M 54.80% | 251.56M 212.59% | 1.455B 478.39% | 2.194B 50.79% | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -449.7M 20.29% | -536.2M -19.24% | -267.824M 50.05% | 222.98M 183.26% | 1.226B 449.83% | 1.799B 46.74% | 2.283B 26.90% | 2.142B -6.18% | 2.154B 0.56% | 2.14B -0.65% | 2.249B 5.09% | 2.386B 6.09% | |
| Operating Margin | -64.07% | -57.47% | -21.54% | 11.77% | 38.13% | 45.24% | 51.07% | 47.32% | 48.90% | 47.65% | 49.32% | 51.02% | |
| EPS YoY % growth | -6.01 7.40% | -8.03 -33.61% | -6.12 23.79% | 2.65 143.28% | 11.39 329.92% | 15.89 39.53% | 18.78 18.23% | 18.23 -2.96% | 17.15 -5.90% | 18.81 9.66% | 17.70 -5.88% | 16.94 -4.32% |
All data in USD
| Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 1.92 309.47% | 1.28 245.63% | 2.85 3,970.28% | 2.96 770.33% | 3.28 70.42% | 3.18 148.85% | 3.57 25.30% | 3.90 31.67% | 4.09 24.55% |
| Revenue Q2Q % growth | 629.08M 58.55% | 705.43M 70.61% | 780.8M 115.14% | 830.64M 77.80% | 892.44M 41.86% | 921.64M 30.65% | 953.97M 22.18% | 1.017B 22.44% | 1.045B 17.09% |
| EBITDA Q2Q % growth | 243.33M 252.54% | 126.38M 189.54% | 218.59M 1,204.08% | 358.84M 625.44% | 413.71M 70.02% | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | 185.11M 651.72% | 166.79M 377.84% | 283.85M 40,592.15% | 313.14M 1,310.79% | 342.4M 84.97% | 358.27M 114.80% | 403.1M 42.01% | 443.58M 41.66% | 459.44M 34.18% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | 0.34 173.91% | -0.14 | 0.48 | 348.76% |
| Q2 2024 Q2Q % growth | 0.07 125.93% | 0.01 | 0.06 | 1,173.24% |
| Q1 2024 Q2Q % growth | 0.37 106.31% | -0.08 | 0.45 | 585.99% |
| Q4 2023 Q2Q % growth | 0.47 137.90% | 0.02 | 0.45 | 3,019.73% |
| Q3 2023 Q2Q % growth | -0.46 84.35% | -1.26 | 0.80 | 63.36% |
| Q2 2023 Q2Q % growth | -0.27 89.81% | -1.81 | 1.54 | 85.10% |
| Q1 2023 Q2Q % growth | -5.86 -388.33% | -1.41 | -4.45 | -315.34% |
| Q4 2022 Q2Q % growth | -1.24 12.68% | -1.37 | 0.13 | 9.79% |
| Q3 2022 Q2Q % growth | -2.94 -1,447.37% | -1.46 | -1.48 | -101.24% |
| Q2 2022 Q2Q % growth | -2.65 -15.22% | -1.20 | -1.45 | -120.48% |
| Q1 2022 Q2Q % growth | -1.20 42.86% | -1.30 | 0.10 | 7.43% |
| Q4 2021 Q2Q % growth | -1.42 40.83% | -1.15 | -0.27 | -23.12% |
| Q3 2021 Q2Q % growth | -0.19 90.16% | -1.93 | 1.74 | 90.17% |
| Q2 2021 Q2Q % growth | -2.30 -19.17% | -1.30 | -1.00 | -76.76% |
| Q1 2021 Q2Q % growth | -2.10 -813.04% | -1.78 | -0.32 | -18.05% |
| Q4 2020 Q2Q % growth | -2.40 24.05% | -1.92 | -0.48 | -25.20% |
| Q3 2020 Q2Q % growth | -1.93 -13.53% | -1.75 | -0.18 | -10.52% |
| Q2 2020 Q2Q % growth | -1.93 -38.85% | -1.79 | -0.14 | -7.69% |
| Q1 2020 Q2Q % growth | -0.23 78.50% | -1.91 | 1.68 | 87.98% |
| Q4 2019 Q2Q % growth | -3.16 | -1.90 | -1.26 | -66.36% |
| Q3 2019 Q2Q % growth | -1.70 | -1.38 | -0.32 | -23.51% |
| Q2 2019 Q2Q % growth | -1.39 | -1.40 | 0.01 | 0.80% |
| Q1 2019 Q2Q % growth | -1.07 | -1.73 | 0.66 | 38.31% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | 467.172M 40.79% | 417.48M | 49.692M | 11.90% |
| Q2 2024 Q2Q % growth | 362.931M 38.93% | 399.23M | -36.299M | -9.09% |
| Q1 2024 Q2Q % growth | 413.464M 63.10% | 385.34M | 28.124M | 7.30% |
| Q4 2023 Q2Q % growth | 396.781M 53.55% | 394.03M | 2.751M | 0.70% |
| Q3 2023 Q2Q % growth | 331.817M 44.08% | 291.04M | 40.777M | 14.01% |
| Q2 2023 Q2Q % growth | 261.238M 11.88% | 264.74M | -3.502M | -1.32% |
| Q1 2023 Q2Q % growth | 253.5M 20.26% | 246.79M | 6.71M | 2.72% |
| Q4 2022 Q2Q % growth | 258.4M 28.24% | 253.3M | 5.1M | 2.01% |
| Q3 2022 Q2Q % growth | 230.3M 21.59% | 239.21M | -8.91M | -3.72% |
| Q2 2022 Q2Q % growth | 233.5M 42.29% | 225.23M | 8.27M | 3.67% |
| Q1 2022 Q2Q % growth | 210.8M 43.50% | 210.57M | 230K | 0.11% |
| Q4 2021 Q2Q % growth | 201.5M 38.87% | 202.58M | -1.08M | -0.53% |
| Q3 2021 Q2Q % growth | 189.4M 31.62% | 176.89M | 12.51M | 7.07% |
| Q2 2021 Q2Q % growth | 164.1M 19.43% | 165.91M | -1.81M | -1.09% |
| Q1 2021 Q2Q % growth | 146.9M 29.20% | 146.2M | 700K | 0.48% |
| Q4 2020 Q2Q % growth | 145.1M 44.96% | 149.22M | -4.12M | -2.76% |
| Q3 2020 Q2Q % growth | 143.9M 45.35% | 140.18M | 3.72M | 2.65% |
| Q2 2020 Q2Q % growth | 137.4M 45.09% | 119.47M | 17.93M | 15.01% |
| Q1 2020 Q2Q % growth | 113.7M 30.69% | 121.42M | -7.72M | -6.36% |
| Q4 2019 Q2Q % growth | 100.1M | 100.83M | -730K | -0.72% |
| Q3 2019 Q2Q % growth | 99M | 100.3M | -1.3M | -1.30% |
| Q2 2019 Q2Q % growth | 94.7M | 92.757M | 1.943M | 2.09% |
| Q1 2019 Q2Q % growth | 87M | 88.285M | -1.285M | -1.46% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 26.42% | -12.66% | 16.65% | 57.28% |
| Revenue | 3.13% | -0.34% | 1.18% | 6.34% |